Please login or sign up to post and edit reviews.
Investing in Cannabis: Canada VS United States
Publisher |
Josh Kincaid
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
May 18, 2021
Episode Duration |
00:08:10

Viridian Capital Advisors Chart of the Week has the top five cannabis market cap U.S. stocks (Curaleaf, Cresco, GTI, TerrAscend & Verano) versus their Canadian counterparts (Aurora, Canopy, Cronos, Sundial & Tilray) where each stock’s price equaled 100% on February 19th, the approximate top of the market. Since February 19th, the prices of the top U.S. stocks have fallen 18.7% while their Canadian counterparts have fallen 38.7%.

We believe the market action reflects several realizations: ~U.S. Federal legalization may not come as quickly or easily as many had hoped. ~The benefits of positive legislation easing banking restrictions and possibly lessening the burden of 280e will accrue primarily to the U.S. competitors. ~The US MSOs are consolidating their positions in a manner that will make it difficult for Canadian competitors to assail, even if legally allowed. ~Recent earnings releases point to the structural lack of profitability of the Canadian LPs, an issue that does not seem to be going away.

The five Canadian companies now trade at an average revenue multiple of 13.6x vs 5.99x for the U.S. companies. Investors should look to rebalance their portfolios to greater weighting of the better valued, more profitable, and faster growing U.S. competitors.

Show Notes: Is the Market Becoming at Least Relatively Rational? https://www.viridianca.com/chart1

Guest: Katrina Glogowski, Seattle Attorney & Angel Investor https://www.linkedin.com/in/katrina-glogowski-711a985/

Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/

Episode 719 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com

Music Info: Song: Beat | Keep On | 2020 Artist: Milochromatic Beats & Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018 Artist: LuxrayBeats

Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data

Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.

Viridian Capital Advisors Chart of the Week has the top five cannabis market cap U.S. stocks. Since February 19th, the prices of the top U.S. stocks have fallen 18.7% while their Canadian counterparts have fallen 38.7%. The five Canadian companies now trade at an average revenue multiple of 13.6x vs 5.99x for the U.S. companies. Investors should look to rebalance their portfolios to greater weighting of the better valued, more profitable, and faster growing U.S. competitors.

Viridian Capital Advisors Chart of the Week has the top five cannabis market cap U.S. stocks (Curaleaf, Cresco, GTI, TerrAscend & Verano) versus their Canadian counterparts (Aurora, Canopy, Cronos, Sundial & Tilray) where each stock’s price equaled 100% on February 19th, the approximate top of the market. Since February 19th, the prices of the top U.S. stocks have fallen 18.7% while their Canadian counterparts have fallen 38.7%.

We believe the market action reflects several realizations: ~U.S. Federal legalization may not come as quickly or easily as many had hoped. ~The benefits of positive legislation easing banking restrictions and possibly lessening the burden of 280e will accrue primarily to the U.S. competitors. ~The US MSOs are consolidating their positions in a manner that will make it difficult for Canadian competitors to assail, even if legally allowed. ~Recent earnings releases point to the structural lack of profitability of the Canadian LPs, an issue that does not seem to be going away.

The five Canadian companies now trade at an average revenue multiple of 13.6x vs 5.99x for the U.S. companies. Investors should look to rebalance their portfolios to greater weighting of the better valued, more profitable, and faster growing U.S. competitors.

Show Notes: Is the Market Becoming at Least Relatively Rational? https://www.viridianca.com/chart1

Guest: Katrina Glogowski, Seattle Attorney & Angel Investor https://www.linkedin.com/in/katrina-glogowski-711a985/

Host: Josh Kincaid, Capital Markets Analyst & host of your cannabis business podcast. https://www.linkedin.com/in/joshkincaid/

Episode 719 of The Talking Hedge: Your Cannabis Business Podcast. ​Covering cannabis products, reviews, business news, interviews, investments, events, and more. https://www.theTalkingHedgepodcast.com

Music Info: Song: Beat | Keep On | 2020 Artist: Milochromatic Beats & Song: Dark Trap Beats Hard Rap Instrumental | Gang | 2018 Artist: LuxrayBeats

Keywords: Hemp News, Weed News, Cannabis News, Marijuana News, Cannabis Business, Marijuana Business, Cannabis Industry News, Marijuana Industry News, Weed News 420, Talking Hedge Podcast, Cannabis Podcast, Marijuana Podcast, Business Podcast, CBD podcast, THC podcast, Cannabis Pitch Deck, Marijuana Pitch Deck, Marijuana Investment Deck, Cannabis Investment Deck, Cannabis Compliance, Cannabis Data, Cannabis Banking, Cannabis Investment, Pot Stocks, Cannabis Stocks, Weed Stocks, Marijuana Stocks, Cannabis Data, Marijuana Data, Cannabis Analytics, Marijuana Analytics, Cannabis Sales Data, Marijuana Sales Data

Josh is not an investment adviser. The Talking Hedge is long gold and silver. Listeners should always speak to their personal financial advisers.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review